InvestorsHub Logo
Followers 3
Posts 107
Boards Moderated 0
Alias Born 07/02/2013

Re: selinpinar post# 11185

Sunday, 05/04/2014 11:21:38 AM

Sunday, May 04, 2014 11:21:38 AM

Post# of 54998
I think the company he is reffering to is GWPH, a biopharmaceutical company. They are not a plant bio tech company.

Here is info about them:
GW Pharmaceuticals plc, a biopharmaceutical company, together with its subsidiaries, is engaged in discovering, developing, and commercializing cannabinoid prescription medicines. The company operates through three segments: Sativex Commercial, Sativex Research and Development, and Pipeline Research and Development. The company primarily offers Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain, and neuropathic pain. It also focuses on the Phase III clinical development program of Sativex for use in the treatment of cancer pain. In addition, the company?s product pipeline includes an orphan childhood epilepsy program, as well as other product candidates in Phase I and II clinical development for the treatment of glioma, ulcerative colitis, type-2 diabetes, and schizophrenia. It has a strategic alliance with Otsuka Pharmaceutical Co., Ltd. The company operates in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Salisbury, the United Kingdom.

I believe XXII is the plant biotech, which can alter the genes of tobacco and other plants

GLTA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News